Skip to main content
. 2021 Oct 8;9(10):e002836. doi: 10.1136/jitc-2021-002836

Figure 8.

Figure 8

Schematic summary of PD-L1 and TIM3/TIGIT combination for OS analysis in patients with ESCC. ESCC, esophageal squamous cell carcinoma; IC, immune checkpoint; PD-L1, programmed cell death 1 ligand 1; TIGIT, T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain; TIM3, T-cell immunoglobulin and mucin-domain-containing-3; TNM, primary tumor, regional lymph node, distant metastasis.